- Home
- KEN vs CNTA Comparison
KEN vs CNTA Comparison
Compare KEN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEN
- CNTA
- Stock Information
- Founded
- KEN 2014
- CNTA 2020
- Country
- KEN Singapore
- CNTA United Kingdom
- Employees
- KEN N/A
- CNTA N/A
- Industry
- KEN Electric Utilities: Central
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- KEN Utilities
- CNTA Health Care
- Exchange
- KEN Nasdaq
- CNTA Nasdaq
- Market Cap
- KEN 2.2B
- CNTA 2.3B
- IPO Year
- KEN N/A
- CNTA 2021
- Fundamental
- Price
- KEN $47.35
- CNTA $16.64
- Analyst Decision
- KEN
- CNTA Strong Buy
- Analyst Count
- KEN 0
- CNTA 10
- Target Price
- KEN N/A
- CNTA $30.56
- AVG Volume (30 Days)
- KEN 15.0K
- CNTA 1.0M
- Earning Date
- KEN 08-08-2025
- CNTA 08-12-2025
- Dividend Yield
- KEN 10.21%
- CNTA N/A
- EPS Growth
- KEN N/A
- CNTA N/A
- EPS
- KEN 9.36
- CNTA N/A
- Revenue
- KEN $774,304,000.00
- CNTA $15,000,000.00
- Revenue This Year
- KEN N/A
- CNTA N/A
- Revenue Next Year
- KEN N/A
- CNTA N/A
- P/E Ratio
- KEN $5.00
- CNTA N/A
- Revenue Growth
- KEN 5.78
- CNTA 118.88
- 52 Week Low
- KEN $24.27
- CNTA $9.60
- 52 Week High
- KEN $49.99
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- KEN 65.78
- CNTA 49.69
- Support Level
- KEN $44.64
- CNTA $16.27
- Resistance Level
- KEN $47.72
- CNTA $16.84
- Average True Range (ATR)
- KEN 0.71
- CNTA 0.70
- MACD
- KEN 0.22
- CNTA -0.21
- Stochastic Oscillator
- KEN 93.23
- CNTA 16.93
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.